Take Our Lyme Survey

KNOWLEDGE IS POWER

Help us learn about what treatments are working for different patients. Texas Lyme Alliance's goal with this survey is to help fill in research gaps for treatments for Lyme patients. We connected three major medical universities to collaborate on this survey to help patients optimize their treatments.

A study approved by the University of Texas at Dallas Institutional Review Board was conducted by Dr. Sarah Maxwell of the University of Texas at Dallas, in collaboration with, and under the expertise of, Dr. Jayakumar Rajadas at Stanford University. The goal of the study was to gather information regarding the effects of various evolving treatments being developed for Lyme disease. This was a patient-reported study that specifically aimed to obtain information regarding the use of disulfiram and any concomitant medications prescribed to treat Lyme disease and coinfections. Data on medication dosing, symptom resolution, and adverse drug effects were studied. All personal patient information remained strictly confidential. This was a research survey, not conducted for medical or diagnostic purposes.

This study has closed and is no longer accepting responses.